A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea - Concepedia

Concepedia

Publication | Open Access

A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea

DOI Full Paper Access

277

Citations

22

References

2018

Year

Fengchun Zhang, Sang‐Cheol Bae, Damon Bass, Myron Chu, Sally Egginton, David Gordon, David A. Roth, Jie Zheng, Yoshiya Tanaka

Annals of the Rheumatic Diseases

Abstract

In patients with SLE from North East Asia, belimumab significantly improved disease activity, while reducing prednisone use, with no new safety issues.

References

	Year	Citations

Page 1